	Eye movement abnormalities in autism spectrum disorder and prodromal psychosis: a review of overlaps and biomarkers. Front Child Adolesc Psychiatry Terman E, Sanilevich L, Zaballos C. PMID: 41909052 [PubMed]
	Memory and learning impairments in deficit and non-deficit schizophrenia: a scoping review. Postep Psychiatr Neurol Plichta P, Mak M, Samochowiec J, Tyburski EM. PMID: 41908881 [PubMed]
	The Clinically Meaningful Score Difference and Meaningful Score Regions in Positive and Negative Syndrome Scale Total Score from Post Hoc Analyses of a Phase 3 Pivotal Clinical Trial of Transdermal Asenapine in Patients with Schizophrenia. Neuropsychiatr Dis Treat Citrome L, Czobor P, Komaroff M, Khan M, Hasebe M, Terahara T. PMID: 41908339 [PubMed]
	Long-Term Trends in the Burden of Schizophrenia in China, 1990-2052: An Analysis of the Global Burden of Disease Study 2023. Psychol Res Behav Manag Song H, Fang L, Li H. PMID: 41907121 [PubMed]
	Cognitive and balance dual-task training for middle-aged and older individuals with schizophrenia: a three-arm randomized controlled trial. Eur Arch Psychiatry Clin Neurosci Chen HY, Wang LT, Chang JJ, Hsu MJ, Wang PW, Hsu HY, Chen MD. PMID: 41906055 [PubMed - as supplied by publisher]
	Japanese Cohort Study and Meta-Analysis Demonstrate Significant Association Between Serotonin Transporter-Linked Polymorphic Region and Schizophrenia. Neuropsychopharmacol Rep Miyachi M, Shirai T, Okada S, Minami K, Tsukamoto R, Mouri K, Okazaki S, Otsuka I, Hishimoto A. PMID: 41905965 [PubMed - indexed for MEDLINE]
	Relapse and its modifiers after antipsychotic discontinuation in first-episode non-affective psychosis: A systematic review and meta-analysis. Eur Neuropsychopharmacol Kishi T, Citrome L, Sakuma K, Hatano M, Iwata N. PMID: 41905135 [PubMed - as supplied by publisher]
	Predicting future mortality risk in first-episode psychosis: External validation of the MIRACLE-FEP machine learning model. Schizophr Res Saarikivi J, Hjellvik V, Tiihonen J, Lähteenvuo M, Taipale H, Odsbu I, Lieslehto J. PMID: 41904923 [PubMed - as supplied by publisher]
	Brain structural abnormalities in treatment-resistant schizophrenia. Mol Psychiatry Etyemez S, Sivananthan R, Faria AV, Iasevoli F, Pontillo G, Di Giorgio A, Chung YC, Kim WS, Odkhuu S, Kwon JS, Kim M, Ha M, Georgiadis F, Milano BA, Kirschner M, Kaiser S, Tordesillas-Gutiérrez D, Sim K, Tan Y, Chan SKW, Turner JA, van Erp TGM, Lee J, Calhoun VD, Sawa A, Yang K. PMID: 41904268 [PubMed - as supplied by publisher]
	Long-acting injectable vs. oral antipsychotics during electroconvulsive therapy in psychosis: a retrospective comparative study. Int Clin Psychopharmacol Jeong HW, Kim YS, Kim EJ, Bhang SY, Choi JW, Jeong JH, Kang H, Lee KY. PMID: 41903948 [PubMed - as supplied by publisher]
	Factors associated with employment and hospitalizations in early-onset psychosis: a clinical study with register-based follow-up. Schizophr Res Andersen NK, Fagerlund B, Jepsen JRM, Hjorthøj C, Lemvigh CK, Rydkjær J, Melau M, Vernal DL, Pagsberg AK. PMID: 41903394 [PubMed - as supplied by publisher]
	Gender differences in working memory impairment and metabolic characteristics among patients with stable schizophrenia: a cross-sectional study. Eur Arch Psychiatry Clin Neurosci Gu J, Lei Q, Liu M, Wang L, Wang Z, Feng Z, Zhang Y, Dong J, Ji Z. PMID: 41902948 [PubMed - as supplied by publisher]
	Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia. JAMA Psychiatry Raabe FJ, Popovic D, Vetter C, Fischer LE, Hasanaj G, Karsli B, Schäfer TJ, Almeida V, Atella A, Gagliardi M, Boudriot E, Yakimov V, Trastulla L, Jiang T, Weyer C, Roell L, Moussiopoulou J, Krcmár L, Galinski S, Papazova I, Pogarell O, Hasan A, Schulte EC, Schmitt A, Koutsouleris N, Levina A, Wagner E, Rossner MJ, Papiol S, Falkai P, Keeser D, Ziller MJ, CDP Working Group. PMID: 41902754 [PubMed - as supplied by publisher]
	A Pilot Study of the Peer Supported Family Intervention, Psychosis Recovery by Enabling Adult Carers at Home (Psychosis-REACH) in an Early Psychosis Clinic. Early Interv Psychiatry Lean M, Benitah KC, Wakeham DE, Chang L, Virtheim D, Runestad S, Kopelovich SL, Hardy KV. PMID: 41902572 [PubMed - indexed for MEDLINE]
	Can the Posterior Segment Findings of the Eye and Serum Microbiota Metabolites Be a Biomarker in Schizophrenia? Medicina (Kaunas) Keser S, Y, Ayd, Kele, Aksoy A, Emre E. PMID: 41901608 [PubMed - indexed for MEDLINE]
	Does Administration of Low-Dose Aspirin Enhance the Efficacy of Psychotropic Drugs in Patients with Bipolar Disorder, Schizophrenia, and Schizoaffective Disorder? Pharmaceuticals (Basel) Stern L, Agam G, Shvartsur R, Alhoashla A, Abu Tailakh M, Azab AN. PMID: 41901282 [PubMed]
	Burden, Incidence, and Spatial Distribution of Schizophrenia in Ecuador (2010-2021): A Nationwide Hospital Discharge Analysis. Int J Environ Res Public Health Rodríguez-Lorenzana A, Carrington SJ, Coral-Almeida M, Álvarez-Mejía D, Torres-Tapia M, Mascialino G. PMID: 41899687 [PubMed - indexed for MEDLINE]
	Phosphatase Signaling as a Therapeutic Strategy in Schizophrenia. Int J Mol Sci Molony LE, Tautz L. PMID: 41898681 [PubMed - indexed for MEDLINE]
	From Signal to Symptom: EEG Paroxysms and Background Slowing as Potential Biomarkers and Compensatory Failures in Treatment-Resistant Schizophrenia. Biomedicines Panov G, Panova P, Dyulgerova S, Chakarov I. PMID: 41898287 [PubMed]
	Exploring attachment, trauma, and cannabis use in psychotic disorders: a qualitative study of patient and family perspectives. BMC Psychiatry Carley S, Laprairie R, Adams S, Adams GC. PMID: 41896797 [PubMed - as supplied by publisher]

Articles 1 - 20 / 68432

Page 1 of 3422



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy